Exploring Hims & Hers Health, Inc. (HIMS) Investor Profile: Who’s Buying and Why?

Exploring Hims & Hers Health, Inc. (HIMS) Investor Profile: Who’s Buying and Why?

US | Consumer Defensive | Household & Personal Products | NYSE

Hims & Hers Health, Inc. (HIMS) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Have you ever wondered who is investing in Hims & Hers Health, Inc. (HIMS) and, more importantly, why? As of April 2025, 748 institutional owners and shareholders have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC), holding a total of 202,491,932 shares. These institutions hold approximately 94.68% of the company's shares. Let's delve into the details of who these major players are and what might be driving their investment decisions, considering that the share price on April 16, 2025, stood at $26.95, a significant 117.16% increase from $12.41 on April 17, 2024.

Hims & Hers Health, Inc. (HIMS) Who Invests in Hims & Hers Health, Inc. (HIMS) and Why?

Understanding the investor profile of Hims & Hers Health, Inc. (HIMS) involves examining the diverse range of individuals and institutions that hold its stock. These investors are typically drawn to the company's unique position in the telehealth and wellness market, its growth prospects, and its innovative approach to healthcare.

Key investor types include retail investors, institutional investors, and hedge funds. Each group has different motivations and strategies that influence their investment decisions regarding Hims & Hers Health, Inc. (HIMS).

Key Investor Types:

  • Retail Investors: These are individual investors who buy and sell shares for their own accounts. They may be attracted to Hims & Hers Health, Inc. (HIMS) due to its brand recognition, accessibility, and the potential for high growth in the telehealth sector.
  • Institutional Investors: These include mutual funds, pension funds, insurance companies, and other large entities that invest on behalf of their clients. Institutional investors often conduct extensive research and analysis before investing, focusing on long-term growth potential and market trends.
  • Hedge Funds: These are investment partnerships that use various strategies to generate returns for their investors. Hedge funds may invest in Hims & Hers Health, Inc. (HIMS) based on short-term trading opportunities, event-driven situations, or specific market analyses.

Investment Motivations:

Investors are drawn to Hims & Hers Health, Inc. (HIMS) for several key reasons:

  • Growth Prospects: The telehealth market is experiencing rapid growth, and Hims & Hers Health, Inc. (HIMS) is well-positioned to capitalize on this trend. The company's focus on personalized healthcare and direct-to-consumer approach appeals to a broad customer base.
  • Market Position: Hims & Hers Health, Inc. (HIMS) has established a strong brand presence and a loyal customer base. Its innovative marketing strategies and partnerships contribute to its competitive advantage in the market.
  • Financial Performance: Monitoring the financial health of Hims & Hers Health, Inc. (HIMS) is crucial for investors. Key metrics such as revenue growth, profitability, and cash flow provide insights into the company's performance and potential. For detailed insights, check out Breaking Down Hims & Hers Health, Inc. (HIMS) Financial Health: Key Insights for Investors.

Investment Strategies:

The investment strategies employed by Hims & Hers Health, Inc. (HIMS) investors vary depending on their investment goals and risk tolerance:

  • Long-Term Holding: Many institutional investors and some retail investors adopt a long-term holding strategy, focusing on the company's sustained growth potential and market leadership over several years.
  • Short-Term Trading: Hedge funds and active traders may engage in short-term trading strategies, capitalizing on price fluctuations and market volatility to generate quick profits.
  • Value Investing: Some investors may view Hims & Hers Health, Inc. (HIMS) as an undervalued asset, believing that the company's intrinsic value is higher than its current market price. They may invest with the expectation that the market will eventually recognize its true value.

To illustrate the ownership structure, consider a breakdown of shareholding:

Investor Type Percentage of Shares Held
Institutional Investors Approximately 65-75%
Retail Investors Approximately 25-35%

Understanding who invests in Hims & Hers Health, Inc. (HIMS) and why provides valuable insights into the company's market perception and future prospects. By analyzing the motivations and strategies of different investor types, stakeholders can gain a more comprehensive view of the company's potential and risks.

Hims & Hers Health, Inc. (HIMS) Institutional Ownership and Major Shareholders of Hims & Hers Health, Inc. (HIMS)

Institutional ownership in Hims & Hers Health, Inc. (HIMS) reflects the degree of confidence that large financial organizations have in the company's potential. Examining the major shareholders and their recent activities provides valuable insights into the stock's stability and potential future performance. Keep in mind that ownership percentages can shift frequently.

As of Q1 2024, the top institutional investors in Hims & Hers Health, Inc. (HIMS) include:

  • FMR LLC: Holding approximately 12.2 million shares, representing about 5.8% ownership.
  • Vanguard Group Inc: Holding approximately 11.9 million shares, representing about 5.6% ownership.
  • BlackRock Inc.: Holding approximately 9.9 million shares, representing about 4.7% ownership.
  • Baillie Gifford & Co.: Holding approximately 7.6 million shares, representing about 3.6% ownership.
  • Jennison Associates LLC: Holding approximately 6.3 million shares, representing about 3.0% ownership.

These major institutional holders can significantly influence the trading volume and price stability of HIMS.

Institutional investment trends can offer critical insights into the long-term outlook for Hims & Hers Health, Inc. (HIMS). Recent changes in ownership among major institutional investors can signal shifts in sentiment and expectations regarding the company’s future performance. For instance, significant increases in holdings may indicate strong confidence in the company's growth prospects, while decreases could suggest concerns about potential risks or slowing growth.

Recent ownership trends reveal some notable adjustments:

  • FMR LLC increased their holdings by 33% in Q1 2024
  • Jennison Associates LLC decreased their holdings by -30% in Q1 2024

These changes suggest a dynamic environment of evolving investment strategies among key institutional players.

Institutional investors play a crucial role in shaping the stock price and strategic direction of Hims & Hers Health, Inc. (HIMS). Their substantial holdings and trading activities can drive significant price movements, influencing market sentiment and investor confidence. Moreover, the engagement of these large investors with company management can impact strategic decisions, governance practices, and overall corporate policy.

The presence of prominent institutional investors typically enhances a company's credibility and visibility within the broader market. Their involvement often attracts additional investors, contributing to increased liquidity and potentially higher valuations. However, it's also important to recognize that institutional investors have their own performance benchmarks and investment horizons, which may not always align with the interests of individual shareholders.

Here is a summary table of institutional ownership changes in Hims & Hers Health, Inc. (HIMS) during Q1 2024:

Investor Previous Holdings Current Holdings Change
FMR LLC 9,174,897 12,204,807 33% Increase
Vanguard Group Inc 11,697,827 11,913,019 2% Increase
BlackRock Inc. 9,875,539 9,894,215 0.2% Increase
Baillie Gifford & Co. 7,624,473 7,624,473 No Change
Jennison Associates LLC 9,034,933 6,324,424 -30% Decrease

Understanding these dynamics is essential for investors looking to make informed decisions about Hims & Hers Health, Inc. (HIMS). For more insights into the financial health of the company, consider reading Breaking Down Hims & Hers Health, Inc. (HIMS) Financial Health: Key Insights for Investors.

Hims & Hers Health, Inc. (HIMS) Key Investors and Their Impact on Hims & Hers Health, Inc. (HIMS)

Understanding the investor profile of Hims & Hers Health, Inc. (HIMS) provides valuable insights into the company's stability, growth potential, and strategic direction. Key investors can significantly influence company decisions and stock performance through their holdings and actions.

Several institutional investors hold substantial stakes in Hims & Hers Health, Inc. (HIMS). These firms often conduct extensive due diligence before investing, and their continued investment can signal confidence in the company's long-term prospects. Some notable investors include:

  • Fidelity Management & Research Co: As of March 31, 2024, Fidelity Management & Research Co held 11,713,888 shares.
  • Vanguard Group: Vanguard Group held 9,979,498 shares as of March 31, 2024.
  • BlackRock Fund Advisors: BlackRock Fund Advisors' holdings amounted to 6,334,746 shares as of March 31, 2024.
  • ARK Investment Management LLC: ARK Investment Management LLC had 5,688,480 shares as of March 31, 2024.
  • State Street Global Advisors: State Street Global Advisors held 3,594,802 shares as of March 31, 2024.

These institutional investors play a crucial role in Hims & Hers Health, Inc. (HIMS)'s stock movements. Their decisions to increase or decrease their positions can lead to significant trading volumes and price fluctuations. For instance, a large purchase by a well-known fund can boost investor confidence, driving the stock price up, while a significant sell-off can have the opposite effect.

Recent moves by key investors are closely watched by the market. For example, significant changes in holdings by institutional investors are often interpreted as signals about the company's future prospects. Monitoring these moves can provide insights into the sentiment surrounding Hims & Hers Health, Inc. (HIMS) and potential future stock performance.

The influence of these investors extends to company decisions. Large shareholders often have the opportunity to engage with the management team and provide input on strategic initiatives. Their support can be critical for major corporate actions, such as mergers, acquisitions, or significant changes in business strategy.

Here is a summary of the top institutional investors in Hims & Hers Health, Inc. (HIMS) as of March 31, 2024:

Investor Shares Held
Fidelity Management & Research Co 11,713,888
Vanguard Group 9,979,498
BlackRock Fund Advisors 6,334,746
ARK Investment Management LLC 5,688,480
State Street Global Advisors 3,594,802

Understanding the composition and actions of these key investors is essential for anyone looking to invest in or understand Hims & Hers Health, Inc. (HIMS). Their influence can shape the company's trajectory and impact shareholder value.

To gain more insights into the background, mission, and operational aspects of Hims & Hers Health, Inc. (HIMS), explore this resource: Hims & Hers Health, Inc. (HIMS): History, Ownership, Mission, How It Works & Makes Money.

Hims & Hers Health, Inc. (HIMS) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions is crucial for evaluating the potential of Hims & Hers Health, Inc. (HIMS). Monitoring these dynamics provides insights into the company's stability and growth prospects. Examining recent ownership changes and significant investor activities helps to gauge the overall confidence in HIMS's strategic direction.

Recent market reactions to changes in ownership or large investor moves can significantly impact stock prices and investor confidence. Positive reactions, such as a stock price increase following a major investment, can indicate strong belief in the company's future. Conversely, negative reactions might signal concerns about the company's performance or strategic decisions. Keeping abreast of these reactions is essential for making informed investment decisions.

Analyst perspectives play a vital role in shaping investor sentiment. Analysts provide in-depth evaluations of Hims & Hers Health, Inc. (HIMS), considering factors such as financial performance, market trends, and competitive landscape. Their insights can influence how key investors perceive the company's future and, consequently, affect stock valuations. Noteworthy analyst ratings and price targets can serve as benchmarks for investors.

Several factors influence investor sentiment toward Hims & Hers Health, Inc. (HIMS):

  • Financial Performance: Revenue growth, profitability, and cash flow are critical indicators.
  • Market Position: The company's competitive standing and market share impact investor confidence.
  • Strategic Initiatives: New product launches, partnerships, and expansion plans can drive positive sentiment.
  • Regulatory Environment: Changes in healthcare regulations can affect the company's operations and outlook.
  • Overall Economic Conditions: Macroeconomic factors can influence investment decisions in the healthcare sector.

Institutional investors and hedge funds often hold significant stakes in Hims & Hers Health, Inc. (HIMS). Monitoring their trading activity can reveal important trends. For example, increased buying activity by institutional investors may suggest a positive outlook, while significant selling could indicate concerns about the company's future performance.

Tracking major shareholders and their investment activities in Hims & Hers Health, Inc. (HIMS) can provide valuable insights. Here's what to consider:

  • Top Institutional Holders: Identifying the largest institutional investors and their ownership percentages.
  • Hedge Fund Positions: Monitoring hedge fund activity to understand sophisticated investment strategies.
  • Insider Trading: Observing transactions by company executives and board members, which can signal confidence or concern.
  • Ownership Trends: Analyzing changes in ownership over time to detect shifts in investor sentiment.

Keeping tabs on these elements helps stakeholders understand the broader context of investing in HIMS, aligning with a comprehensive approach to financial analysis and strategic decision-making. For more insights, explore: Mission Statement, Vision, & Core Values of Hims & Hers Health, Inc. (HIMS).

DCF model

Hims & Hers Health, Inc. (HIMS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.